Novavax and Serum Institute of India Receive Emergency Use Authorization
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next generation
Stay updated with breaking news from Badan Peng. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next generation
GAITHERSBURG, Md. and PUNE, India, Nov. 1, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and comm...
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...
Biotechnology firm Novavax Inc and its partner Serum Institute of India on Monday said they have received the first emergency use authorisation (EUA) for Novavax''s COVID-19 vaccine, in Indonesia.